Data Collective IV GP, LLC — Q4 2025 13F-HR

← Data Collective IV GP, LLC

Q4 2025 · 13F-HR

Data Collective IV GP, LLCholdings as filed

Filed 2026-02-17 · accession 0001104659-26-015677

$58.5M

Reported value

Positions

2025-12-31

Period end

View analyzed profile →PRO

The Brief · Data Collective IV GP, LLC · Q4 2025

AI · grounded in 13F

Data Collective IV GP, LLC closed its position in Roivant Sciences Ltd., reducing its holdings by $58,629. The fund also trimmed its stake in Evolv Technologies Holdings, Inc. EVLV by 8.2%. These moves reduced the fund's total position count to three.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
30049H102	EVLV	Evolv Technologies Holdings, Inc.	$32.9M	56.2%	4,590,000	Common	SOLE
75629V104	RXRX	Recursion Pharmaceuticals, Inc.	$24.3M	41.5%	5,941,120	Common	SOLE
60255C885	BRD1EUR	Mind Medicine (MindMed) Inc.	$1.3M	2.30%	100,350	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.